Schedule 13G ownership disclosure

OPIANT PHARMACEUTICALS INC

Security class unavailable · CUSIP: 683750103

Event date: 2022-11-16

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
7.4000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001193125-22-293384
Form type
SC 13G
Filer
OPIANT PHARMACEUTICALS, INC.
CIK
CIK 1385508
Filed
Nov 28, 2022
Reporting period
Nov 16, 2022
Description
Schedule 13G beneficial ownership

Explore SEC Filings Hub